So excited to share our new @science.org podcast limited series The Normals! Out now!!
Listen here: www.science.org/content/podc...
Happy to announce publication of our first therapeutic mRNA-LNP paper!
In vivo reprogramming of cytotoxic effector CD8 T cells via fractalkine-conjugated mRNA-LNPs | Science Immunology www.science.org/doi/10.1126/...
Scientists in Dr. @davidraulet.bsky.social's lab at @ucberkeleyofficial.bsky.social have shown that removing tumor Tregs unleashes NK cell responses to control cancers, including MHC I–deficient tumors.
📄 Read the paper: https://bit.ly/4uoezPs
🎙️ Tune in: https://bit.ly/4f2ci85
In #Science #Immunology Bali Pulendran's lab at @stanfordmedicine.bsky.social tests 5 different #LLM models to see how well they can accelerate #vaccine #research in combination with human creativity.
www.science.org/doi/10.1126/... 🧪🧫🥼💻
#Science #Immunology will be sponsoring a prize for the best poster presentation! The abstract deadline is fast approaching though, so don't delay!
I hope to see many of you in marvelous Ghent this coming March!
Video
The January 2026 issue of #ScienceImmunology is out!
This month's cover depicts the repopulation of resident cardiac macrophages after chemotherapy, protecting the heart against subsequent injury. Learn more about this research and more: https://scim.ag/3NsLjqu
Science has named the seemingly unstoppable growth of renewable energy worldwide as the 2025 Breakthrough of the Year.
Learn more about this year's #BOTY and other big advances in science: https://scim.ag/493Tpgx
An accompanying Focus by John Tsang (@tsanglab.bsky.social) provides a broader perspective of #AI & #immunology.
www.science.org/doi/10.1126/...
We wanted to put over a decade of advances on the immunology surrounding fetal Zika infection in context in our review "Immune mechanisms of congenital Zika syndrome"
@sciimmunology.bsky.social. So happy to see it's #openaccess! www.science.org/doi/10.1126/...
To mark World #Malaria Day, here are 2 recent Science #Immunology papers highlighting cutting-edge malaria research!
Nideffer & al. (2025)
scim.ag/4izhn63
Gao & al. (2025)
scim.ag/4hN5vOY
Fractalkine-conjugated mRNA-LNPs effectively target cytotoxic effector CD8 T cells for transient in vivo reprogramming.
In partnership with @vibtrainconf.bsky.social, #ScienceImmunology is organizing #Type2Immunity26 in Ghent 9–10 March 2026, bringing together leaders in the field of #Type2Immunity.
Check out our lineup here: vibbio.tech/3UwmTNk
🗓️15 DEC: Travel grant deadline
🗓️8 JAN: Abstract deadline
